SYDNEY, Australia -- Biota Holdings Ltd., which is still feeling the effects of the poor sales performance of its anti-flu drug, has announced a management revamp as part of a strategic review of the company.
The changes are mostly internal and involve more emphasis on business development, but also include the retirement of Chief Executive Hugh Niall, who has run the Melbourne-based company for six years. Niall, 64, will step down next year and does not plan to move on into any full-time position.
Niall told BioWorld International that his retirement was not related to the management review. "I have been running the company for six years and it's probably about time …
No comments:
Post a Comment